# SEG Drug HTML Owner Review Record

**Record ID:** `SEG_DRUG_HTML_OWNER_REVIEW_RECORD`  
**Mode:** `CONTROLLED OWNER GOVERNED REVIEW`  
**Review pathway:** `OWNER_GOVERNED_MEDICAL_REVIEW_PATHWAY`  
**Source:** Drug HTML  
**Ownership:** `SEG_INTERNAL_ASSET` for the declared retained artifact scope

## 1. Review owner and authority

| Field | Value |
|---|---|
| Review owner/authority | Dr. Alaa Al-Asfar |
| Recorded roles | SEG Medical Content Owner; Emergency Medicine Physician; Project Lead |
| Authority basis | User-declared owner authority and `SEG_OWNER_REVIEW_AUTHORITY_POLICY.md` |
| Review identity status | Owner authority is identified; a completed owner-executed clinical review event is not supplied in the input |
| Record timestamp | `2026-08-22T14:54:41+00:00` — record/batch execution timestamp |
| Clinical review date | `NOT_SUPPLIED` — must not be inferred from the record timestamp |
| Qualification evidence | Role is user-declared; separate credential evidence is `NOT_SUPPLIED` |
| Conflict declaration | `NOT_SUPPLIED` |

This record documents a controlled owner-governed review attempt and its evidence boundary. It does not claim that a clinical or drug-safety review was completed.

## 2. Locked artifact identity

| Field | Value |
|---|---|
| Artifact ID | `LOCAL_INTAKE_ARTIFACT` |
| Artifact path | `/home/ubuntu/upload/deepseek_html_20260615_a3266b.html` |
| Artifact size | 25,918 bytes |
| Artifact line count | 394 lines |
| SHA-256 | `5367711d08df2393cf852815b1b9d0ad4dac8240ac061cd88c71a53884e938ac` |
| Canonical source/version | `NOT_AVAILABLE` |
| Original locator | `NOT_AVAILABLE` |
| Artifact-to-source relationship | Partial artifact-level evidence only; canonical relationship unresolved |

The hash and structural observations establish retained-artifact continuity only. They do not establish clinical correctness, currentness, canonical source identity, or rights clearance.[1] [2]

## 3. Review scope and criteria

The owner-governed review scope was defined to cover the following criteria against the unchanged exact artifact:

| Review domain | Required criteria |
|---|---|
| Emergency Medicine relevance | Clinical scope, indications, dose statements, contraindications, clinical context, currency, omissions, ambiguity, conflicts, and exact section/entity locators |
| Drug information structure | Drug entity structure, labels, embedded data, section boundaries, internal consistency, and traceability of represented information |
| Safety considerations | Drug identity, dosing statements, interactions, contraindications, safety signals, omissions, uncertainty, and limits of represented interaction information |
| Metadata validation | Canonical title/source, owner/custodian, version/date, original locator, provenance, track/taxonomy, rights, and audit linkage |

No external approval dependency is assumed solely because the artifact is internally owned. Rights and provenance for any incorporated third-party material remain separate gates.

## 4. Evidence-based findings

The following findings are evidence observations or unresolved requirements, not clinical adjudications:

| Finding ID | Finding | Status |
|---|---|---|
| `DRUG-OR-001` | The locked HTML artifact and SHA-256 are available and match the registered retained representation. | `CONFIRMED` for retained artifact identity |
| `DRUG-OR-002` | Read-only structural observations include 19 `summaryData` sections, 21 `quick` entries, 47 `drugList` entities, and 20 `trapsList` entries. | `PARTIALLY_CONFIRMED` as artifact structure only |
| `DRUG-OR-003` | No explicit pairwise interaction table was observed in the available artifact evidence. This is not a conclusion that interactions are absent. | `OBSERVATION_ONLY` |
| `DRUG-OR-004` | Canonical source identity, version/edition/date, original locator, extraction history, complete provenance, and rights evidence remain unavailable. | `NOT_AVAILABLE` / blocking |
| `DRUG-OR-005` | Clinical accuracy, emergency-medicine relevance, dose safety, contraindication completeness, interaction safety, and currency were not clinically adjudicated in this record. | `NOT_COMPLETED` |
| `DRUG-OR-006` | Metadata validation remains incomplete; missing values must remain `NOT_SUPPLIED`, `NOT_AVAILABLE`, or `UNRESOLVED`. | `BLOCKED` |

No drug fact, dose, interaction, contraindication, safety statement, or clinical correction was added or changed.

## 5. Limitations

This record is limited by the absence of canonical source/version evidence, attributable provenance and rights evidence, a separately dated review event, independent credential evidence, complete current-protocol comparison, and an actual completed owner-executed clinical or Pharmacology/Drug Safety review record. Structural inspection cannot certify clinical accuracy or drug safety. The local file was preserved unchanged.

## 6. Required follow-up

The next allowed action is to record an attributable owner-executed or owner-appointed Emergency Medicine review and a separate Pharmacology/Drug Safety review against the exact artifact and hash. Each review must include the actual review date/time, qualification/role, conflicts, exact sections/entities examined, cited evidence, findings, unresolved issues, disposition, limitations, and append-only audit linkage.

The following evidence also remains required: canonical source/version or an explicit governed treatment of its absence, original locator, provenance and transformation history, rights scope for incorporated material, metadata/track decision, and technical HTML/lineage review. The HTML must remain unchanged and no content record may be created from this record.

## 7. Review decision

`OWNER_REVIEW_BLOCKED`

**Decision basis:** The owner-governed pathway is defined and the retained artifact is locked, but the source/version, provenance, rights, metadata, and completed clinical/drug-safety review evidence are not sufficient to complete the owner review. This decision is not a source rejection and does not grant approval.

## 8. Governance controls

| Control | State |
|---|---|
| Owner-governed pathway | `OWNER_GOVERNED_MEDICAL_REVIEW_PATHWAY` |
| External approval dependency for internal pathway | `NOT_ASSUMED` |
| Third-party rights/provenance gate | `PENDING_REVIEW` / `NOT_AVAILABLE` where not supplied |
| Source approval | `APPROVED_SOURCES = NONE` |
| Normalization | `BLOCKED_PENDING_APPROVED_SOURCE` |
| `READY_FOR_NORMALIZATION` | Not set |
| Content correction/normalization | Not performed |
| Import/activation/publication | Not performed |
| Database/schema/application change | Not performed |

## References

[1]: file:///home/ubuntu/seg-internship-output/SEG_P0_REVIEW_EXECUTION_BATCH_REPORT.md "SEG P0 Review Execution Batch Report"

[2]: file:///home/ubuntu/seg-internship-output/SEG_P0_VERSION_CONTROL_REGISTER.md "SEG P0 Version Control Register"

[3]: file:///home/ubuntu/seg-internship-output/SEG_OWNER_REVIEW_AUTHORITY_POLICY.md "SEG Owner Review Authority Policy"

[4]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_REVIEW_STATUS_v1.md "SEG Drug HTML Review Status v1"

**Document status:** `OWNER_REVIEW_RECORD_BLOCKED_PENDING_SOURCE_REVIEW_EVIDENCE`
